Cellectar Biosciences (CLRB) EPS (Basic) (2010 - 2026)
Cellectar Biosciences (CLRB) posted EPS (Basic) of -$2.24 for Q4 2025, down 41.54% sequentially from -$1.58 in Q3 2025, and up 97.72% YoY from -$1.13 in Q4 2024.
Cellectar Biosciences (CLRB) EPS (Basic) (2010 - 2026) Analysis & Trends
Cellectar Biosciences has reported EPS (Basic) for 16 years, with the latest figure at -$2.24 in Q4 2025.
- Quarterly EPS (Basic) rose 97.72% year-over-year to -$2.24 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.21 (up 93.03% YoY) and the FY2025 annual result came in at -$8.31, up 71.16% from the prior year.
- EPS (Basic) eased to -$2.24 in Q4 2025 per CLRB's latest filing, from -$1.58 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$1.58 in Q3 2025 and troughed at -$341.66 in Q4 2022.
- A 5-year average of -$42.13 and a median of -$27.9 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) plunged 927.11% in 2022, then soared 97.72% in 2025.
- Over 5 years, EPS (Basic) stood at -$33.26 in 2021, then slumped by 927.11% to -$341.66 in 2022, then soared by 89.77% to -$34.93 in 2023, then plunged by 181.95% to -$98.5 in 2024, then jumped by 97.72% to -$2.24 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$2.24, -$1.58, and -$4.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - | -2.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.58 |
| Dec 31, 2025 | -2.24 |
| Sep 30, 2025 | -1.58 |
| Jun 30, 2025 | -4.12 |
| Mar 31, 2025 | -4.27 |
| Dec 31, 2024 | -98.50 |
| Sep 30, 2024 | -10.69 |
| Jun 30, 2024 | -12.09 |
| Mar 31, 2024 | -13.05 |
| Dec 31, 2023 | -34.93 |
| Sep 30, 2023 | -25.65 |
| Jun 30, 2023 | -22.83 |
| Mar 31, 2023 | -23.59 |
| Dec 31, 2022 | -341.66 |
| Sep 30, 2022 | -39.43 |
| Jun 30, 2022 | -36.51 |
| Mar 31, 2022 | -30.15 |
| Dec 31, 2021 | -33.26 |
| Sep 30, 2021 | -31.03 |
| Jun 30, 2021 | -36.62 |